Cutaneous lesions of churg-Strauss syndrome associated with montelukast therapy [9]

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 618-

  Gal, A A ^a   Morris, R J ^a   Pine, J R ^a   Spraker, M K ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MONTELUKAST; PREDNISOLONE; ZAFIRLUKAST;

ANAMNESIS; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HOSPITAL ADMISSION; HUMAN; LETTER; LEUKOCYTE COUNT; MEDICAL LITERATURE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; VASCULITIS;

EID: 0036042726     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.48839.x     Document Type: Letter

References (7)

1. Leukotriene-receptor antagonists
2. Treatment of asthma with drugs modifying the leukotriene pathway
3. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report
4. Montelukast and Churg-Strauss syndrome
5. Churg-Strauss syndrome associated with montelukast therapy
6. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma
7. Churg-Strauss syndrome associated with montelukast